Lipids

The researchers compared the effects of the traditional Mediterranean diet to the green-Mediterranean diet on visceral adipose tissue loss.

The GOULD study is a multicenter, observational registry of patients with atherosclerotic cardiovascular disease in which the primary endpoint was to describe LDL-C treatment patterns over time in patients...

Low levels of LDL cholesterol reduce the risk of cardiovascular disease and events. However, is it safe to reduce LDL cholesterol levels that are already low? A new study investigates.

In a recent study, researchers hypothesized that the adaptability of the novel method could make it more accurate among non-fasting patients.

The FDA has approved a new, monthly dosing option for the PCSK9-inhibitor Praluent (alirocumab).

A recent study sought to examine the effects of acute peanut consumption with a high-fat meal on postprandial lipids and endothelial function in healthy obese and overweight men.

Researchers performed a meta-analysis in order to examine the safety of lowering LDL-C to very low levels using the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab.